Skip to content

Clinical Efficacy and Mechanism Study of Acupuncture on "Ghost Points" for the Treatment of Chronic Insomnia with Depressive Symptoms

Clinical Efficacy and Mechanism Study of Acupuncture on "Ghost Points" for the Treatment of Chronic Insomnia with Depressive Symptoms

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082104
Enrollment
Unknown
Registered
2024-03-20
Start date
2024-03-28
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia with Depressive Symptoms

Interventions

Active Acupuncture Group:1.1 Main Acupoints Shuigou, Daling, Shenmai, Jiache, Chengjiang, Laogong, Shangxing, Quchi 1.2 Localization Reference: "Standard Nomenclature and Localization of Acupoints" of
for Daling, needle straight to a depth of 0.3-0.5 cun
for Shenmai, needle straigh

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Male or female individuals aged 18-65 years old. 2.Meeting the diagnostic criteria for chronic insomnia according to ICSD-3. Severe insomnia is defined as a score >7 on the Insomnia Severity Index (ISI) (indicating clinically significant insomnia). 3.Beck Depression Inventory-II (BDI-II) scores ranging from 14 to 28. 4.Regular use of sedative-hypnotic drugs for at least 3 months prior to study entry or no use of such drugs. 5.Voluntary participation in this study and signing an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Received acupuncture treatment for insomnia in the past 3 months; 2.Unstable use of sedative-hypnotic drugs or antipsychotic drugs within the past month; 3.Diagnosed with severe depression, history of mental illness or organic mental disorders, or severe suicidal tendencies; 4.Sleep disorders due to physical illnesses such as nocturnal discomfort, pain, or breathing difficulties, or insomnia symptoms due to the use of psychoactive substances or drugs; 5.Sleep disorders caused by central nervous system diseases such as Parkinson's disease, Alzheimer's disease, or neurodegenerative diseases such as Louis body dementia; 6.Severe heart, liver, kidney dysfunction, or blood, respiratory system diseases, or infectious diseases such as liver disease, AIDS, and severe trauma that have not healed; 7.History of alcohol abuse or drug dependence; 8.Pregnant or lactating women; 9.Local skin or tissue infection at acupuncture points; 10.Fear of needles or needle phobia; 11.Participation in other research projects in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Insomnia Severity Index;Beck Depression Inventory - Second Edition;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index;Self-Rating Depression Scale;Fatigue Scale-14;Traditional Chinese Medicine Symptom Score Scale;Total Sleep Time;Sleep Efficacy;Wake Bouts;Sleep Onset Latency;

Countries

China

Contacts

Public ContactYunfei Chen

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine

icyf1968@163.com+86 189 3056 8221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026